RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes.

Effect of pioglitazone and rosiglitazone on mediators of endothelial dysfunction, markers of angiogenesis and inflammatory cytokines in type-2 diabetes.

Add to Collection
2009 Mar Others Fist_Author_Year_PM

Full Author : ['Vijay, Sudarshan K', 'Mishra, Manish', 'Kumar, Hemant', 'Tripathi, K']
Journal Title : Acta diabetologica
Chapter : Section3
Journal Year : 2009
Cited by : Not Available

The purpose of this study was to assess the effects of PPAR-gamma agonists (pioglitazone and rosiglitazone) on mediators of endothelial dysfunction and markers of angiogenesis in patients with type-2 diabetes. Pioglitazone group showed favorable reduction.....

Keywords : ["endothelial dysfunction marker", "inflammatory cytokine", "rosiglitazone", "pioglitazone", "mediator", "effect", "diabetes", "angiogenesis"]